US Bancorp
FLGT icon

US Bancorp’s Fulgent Genetics FLGT Stock Holding History

US Bancorp’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.02K Buy
342
+258
+307% +$4.37K ﹤0.01% 3566
2026
Q1 		$1.34K Sell
84
-435
-84% -$9.44K ﹤0.01% 3883
2025
Q4 		$13.6K Buy
519
+31
+6% +$804 ﹤0.01% 3226
2025
Q3 		$11K Sell
488
-87
-15% -$1.79K ﹤0.01% 3283
2025
Q2 		$11.4K Buy
575
+156
+37% +$3.04K ﹤0.01% 3383
2025
Q1 		$7.08K Buy
419
+262
+167% +$4.46K ﹤0.01% 3550
2024
Q4 		$2.9K Sell
157
-344
-69% -$6.72K ﹤0.01% 3778
2024
Q3 		$10.9K Sell
501
-15
-3% -$335 ﹤0.01% 3345
2024
Q2 		$10.1K Buy
516
+323
+167% +$6.74K ﹤0.01% 3298
2024
Q1 		$4.19K Sell
193
-424
-69% -$10.5K ﹤0.01% 3573
2023
Q4 		$17.8K Buy
617
+94
+18% +$2.52K ﹤0.01% 3111
2023
Q3 		$14K Sell
523
-64
-11% -$2.19K ﹤0.01% 3039
2023
Q2 		$21.7K Sell
587
-112
-16% -$3.9K ﹤0.01% 2935
2023
Q1 		$21.8K Buy
699
+478
+216% +$15.4K ﹤0.01% 2948
2022
Q4 		$6.58K Sell
221
-199
-47% -$7.12K ﹤0.01% 3426
2022
Q3 		$16K Sell
420
-73
-15% -$3.66K ﹤0.01% 3143
2022
Q2 		$27K Sell
493
-408
-45% -$22.4K ﹤0.01% 2890
2022
Q1 		$56K Buy
901
+152
+20% +$10K ﹤0.01% 2562
2021
Q4 		$75K Buy
749
+317
+73% +$27.9K ﹤0.01% 2439
2021
Q3 		$39K Sell
432
-193
-31% -$17.5K ﹤0.01% 2765
2021
Q2 		$57K Buy
625
+278
+80% +$22.2K ﹤0.01% 2611
2021
Q1 		$33K Sell
347
-165
-32% -$17K ﹤0.01% 2782
2020
Q4 		$27K Buy
+512
New +$21.4K ﹤0.01% 2771
2020
Q3 		– Sell
-400
Closed -$6K – 3745
2020
Q2 		$6K Buy
+400
New +$6.13K ﹤0.01% 3243

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

US Bancorp's FLGT Position: Q2 2026 in Review

US Bancorp increased its Fulgent Genetics (FLGT) stake by 307% in Q2 2026, buying an estimated $4.37K and bringing the position to 342 shares worth $7.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3566.

US Bancorp first reported a position in FLGT in Q2 2020 and has held it in 24 quarters since. The position peaked at $75K in Q4 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • US Bancorp held 342 shares of Fulgent Genetics worth $7.02K as of Q2 2026.
  • US Bancorp bought 258 Fulgent Genetics shares in Q2 2026, an estimated $4.37K.
  • Fulgent Genetics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3566 holding.
  • US Bancorp first reported a position in Fulgent Genetics in Q2 2020 and has held it in 24 quarters since.
  • US Bancorp's Fulgent Genetics position peaked at $75K in Q4 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.